关注
dean fennell
dean fennell
在 le.ac.uk 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Tracking the evolution of non–small-cell lung cancer
M Jamal-Hanjani, GA Wilson, N McGranahan, NJ Birkbak, TBK Watkins, ...
New England Journal of Medicine 376 (22), 2109-2121, 2017
22362017
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
C Abbosh, NJ Birkbak, GA Wilson, M Jamal-Hanjani, T Constantin, ...
Nature 545 (7655), 446-451, 2017
17262017
Small-cell lung cancer
JP Van Meerbeeck, DA Fennell, DKM De Ruysscher
The Lancet 378 (9804), 1741-1755, 2011
12292011
Allele-specific HLA loss and immune escape in lung cancer evolution
N McGranahan, R Rosenthal, CT Hiley, AJ Rowan, TBK Watkins, ...
Cell 171 (6), 1259-1271. e11, 2017
11952017
Fc effector function contributes to the activity of human anti-CTLA-4 antibodies
FA Vargas, AJS Furness, K Litchfield, K Joshi, R Rosenthal, E Ghorani, ...
Cancer cell 33 (4), 649-663. e4, 2018
5522018
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
B Delage, DA Fennell, L Nicholson, I McNeish, NR Lemoine, T Crook, ...
International journal of cancer 126 (12), 2762-2772, 2010
4452010
Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled …
M Maio, A Scherpereel, L Calabrò, J Aerts, SC Perez, A Bearz, ...
The Lancet Oncology 18 (9), 1261-1273, 2017
4352017
Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors
FA Vargas, AJS Furness, I Solomon, K Joshi, L Mekkaoui, MH Lesko, ...
Immunity 46 (4), 577-586, 2017
4222017
Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
DA Fennell, Y Summers, J Cadranel, T Benepal, DC Christoph, R Lal, ...
Cancer treatment reviews 44, 42-50, 2016
3662016
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P Baas, D Fennell, KM Kerr, PE Van Schil, RL Haas, S Peters
Annals of oncology 26, v31-v39, 2015
3662015
MicroRNA regulation of core apoptosis pathways in cancer
RT Lima, S Busacca, GM Almeida, G Gaudino, DA Fennell, ...
European journal of cancer 47 (2), 163-174, 2011
3412011
Novel insights into mesothelioma biology and implications for therapy
TA Yap, JG Aerts, S Popat, DA Fennell
Nature Reviews Cancer 17 (8), 475-488, 2017
3372017
Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature
MP Barr, SG Gray, AC Hoffmann, RA Hilger, J Thomale, JD O’Flaherty, ...
PloS one 8 (1), e54193, 2013
3172013
Tracking genomic cancer evolution for precision medicine: the lung TRACERx study
M Jamal-Hanjani, A Hackshaw, Y Ngai, J Shaw, C Dive, S Quezada, ...
PLoS biology 12 (7), e1001906, 2014
3102014
The potential of combined immunotherapy and antiangiogenesis for the synergistic treatment of advanced NSCLC
C Manegold, AMC Dingemans, JE Gray, K Nakagawa, M Nicolson, ...
Journal of Thoracic Oncology 12 (2), 194-207, 2017
2332017
In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion
PW Szlosarek, A Klabatsa, A Pallaska, M Sheaff, P Smith, T Crook, ...
Clinical cancer research 12 (23), 7126-7131, 2006
2282006
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
A Scherpereel, I Opitz, T Berghmans, I Psallidas, M Glatzer, D Rigau, ...
European respiratory journal 55 (6), 2020
2182020
Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial
DA Fennell, S Ewings, C Ottensmeier, R Califano, GG Hanna, K Hill, ...
The Lancet Oncology 22 (11), 1530-1540, 2021
214*2021
Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo …
LM Krug, HL Kindler, H Calvert, C Manegold, AS Tsao, D Fennell, ...
The Lancet Oncology 16 (4), 447-456, 2015
2132015
British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma
I Woolhouse, L Bishop, L Darlison, D De Fonseka, A Edey, J Edwards, ...
Thorax 73 (Suppl 1), i1-i30, 2018
2112018
系统目前无法执行此操作,请稍后再试。
文章 1–20